Meissa Vaccines gathers $30 mln Series A

South San Francisco-based Meissa Vaccines, a developer of vaccines to prevent viral respiratory infections, has raised $30 million in Series A financing. The investor was Morningside Ventures. In addition to the funding, Dr. Isaac Cheng and Stephanie O’Brien of Morningside will join Meissa Vaccines' board of directors.

North AmericaUSBriefs